Select a community
HIV
Find out more about the PatientsLikeMe
HIV Community
Home > Community Treatment Reports > Emtricitabine-Tenofovir Treatment Report
What is Emtricitabine-Tenofovir?

Emtricitabine and tenofovir is an antiviral medication that prevents human immunodeficiency virus (HIV) from reproducing in your body. Emtricitabine and tenofovir treats HIV, which causes acquired immunodeficiency syndrome (AIDS).

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Treat my HIV 190 24
Other 7 1
Improve immune function 4 0
Support another treatment 2 0
Don't know 2 0
Fatigue 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
1 4%
Moderate
6 24%
Mild
6 24%
None
12 48%

Most commonly reported side effects

Diarrhea
10 40%
lack of energy
8 32%
Headaches
6 24%
sickness
2 8%
Nausea
1 4%
Loss of appetite
1 4%
  • Mild
  • Moderate
  • Severe

Dosages

Top 10 dosages based on patients currently taking Emtricitabine-Tenofovir. See all 18 dosages ►

  daily 1 daily 1 g daily 1 mg daily 1 other daily 1 tbs. daily 2 daily 25 mg daily 100 mg daily 200 mg daily 245 mg daily 200 mg-300 mg daily 300 mg daily 400 mg daily 500 mg daily 2 x 200 mg-300 mg daily 4 x 200 mg-300 mg daily 8 x 200 mg-300 mg daily
  38 Number of Patients: 38 9 Number of Patients: 9 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 14 Number of Patients: 14 3 Number of Patients: 3 160 Number of Patients: 160 8 Number of Patients: 8 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Stop Reasons

Why Patients Stopped Taking Emtricitabine-Tenofovir (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice
11 41% Doctor's advice: 41%
Other
9 33% Other: 33%
Side effects too severe
4 15% Side effects too severe: 15%
Expense
3 11% Expense: 11%
Course of treatment ended
2 7% Course of treatment ended: 7%
Did not seem to work
1 4% Did not seem to work: 4%
Not indicated
1 4% Not indicated: 4%

See all 25 patients who’ve stopped taking Emtricitabine-Tenofovir

Duration See details about how long patients take this treatment ▼

Currently Taking Emtricitabine-Tenofovir

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
2
10
12
29
32
32

Stopped Taking Emtricitabine-Tenofovir

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
5
3
5
6
6

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
21 84%
Usually
3 12%
Sometimes
0 0%
Never
1 4%

Burden

Difficulty being on treatment

Very
1 4%
Somewhat
1 4%
A little
4 16%
Not at all
19 76%

Cost

Paid out of pocket

$200+
0 0%
$100-199
1 4%
$50-99
2 8%
$25-49
1 4%
< $25
15 60%

See more information, including instructions, precautions, side effects, and interactions.

Report created on November 20, 2009.